iivdc

The 5th International Veterinary Vaccines and Diagnostics Conference


Monona Terrace Convention Center

July 19-23, 2009

Madison, WI USA









 

Important Dates

 

Registration January 9, 2009 $650.00
Registration Graduate Students   $350.00
     
     
Abstract Submission Site Opens February 1, 2009  
Abstract Submission Site Closes June 15, 2009  

 

 


     

Other links of interest to meeting participants:


Dear Colleague,


On July 19 to 24th , 2009 we will host the 5th International Veterinary Vaccines and Diagnostics Conference (IVVDC) in Madison, WI USA.  The First  IVVDC Conference was held in Madison WI in 1997 (Chair R.D. Schultz), the 2nd in Oxford England 2000 (Chair Lewis Thomas), the 3rd in Guelph Canada 2003 (Chair Pat Shewen) and the 4th in Oslo Norway 2006 (Chair Arve Lund).  These were all excellent conferences!  The original and continuing purpose of the IVVDC is to bring together people from the Private Sector (Industry, Veterinary Practice and the Public Sector (Government and Academia) to discuss issues pertaining to the development and use of all Veterinary Vaccines and Diagnostics for multiple animal species.  We decided to hold the 5th IVVDC again in Madison WI to honor many of the individuals, including those that have retired, who have made and continue to make major contributions to Veterinary Immunology and Microbiology and especially to those that have made major contributions in Veterinary Vaccinology and Diagnostics. 

This Conference Series without exception provides more information on vaccines and diagnostics for all veterinary species than any other meeting you can attend.

 

This years’ conference, similar to previous years, will have concurrent Sessions on Vaccines and Diagnostics for multiple species including: Avian and Aquatic, Bovine, Canine and Feline, Equine, Human, Porcine, Wild and Exotic.  Presentations include information on vaccines that not only control or prevent infectious diseases caused by Viruses, Bacteria and/or Parasites, but also vaccines designed for treating, controlling and/or preventing Cancers, Periodontal Disease, Pregnancy, Snakebites, etc.

 

Sessions will also include: Regulations and Licensing; Immunologic Reagents; Food Safety; Basic Immunology (Adaptive and Innate Immunity); Bioterrorism; Foreign Animal Diseases; Adverse Reactions and/or Undesirable Consequences from Vaccines and/or Diagnostics; Marker (DIVA) Vaccines; Herd (Population) Immunity; Specific Disease Eradication Programs; Development of both New Traditional, and Recombinant DNA, Infectious and Non-Infectious Vaccines; Natural Immunization; Traditional and Molecular Methods for Discovery and Diagnosis.

 

You will not want to miss this conference because the information will be presented by experts from around the world with many years of experience on the topics they present.  Also the audience will include many with years of experience in vaccinology, which will provide an opportunity for many very interesting discussions.

 

The 5th  IVVDC is Sponsored by the Following Organizations:

International Veterinary Vaccines and Diagnostics Committee, American Association of Veterinary Immunologists, Veterinary Immunology Committee, AAHA’s Canine Vaccine Task Force, American Association of Feline Practitioners (AAFP) Vaccine Task Force and World Small Animal Veterinary Vaccine Group (WSAVVG)

 

 

Dr. Ronald David Schultz
Professor and Chair
Department of Pathobiological Sciences
School of Veterinary Medicine
University of Wisconsin-Madison

 

Corporate Sponsors include but are not limited to:

merial intervet pfizer idex


Additional Corporate Sponsors will be listed in detail at a later time.

 

 

Program

Sunday, July 19
12:00 Noon – 5:30 PM
Introduction and General Topics

12:00 - 1:00 Welcoming Ceremony
1:00 - 1:45 Tizard, Ian
Dr. Ian Tizard, Professor, Texas A&M University, College Station, TX
Variolation and vaccination in domestic animals – the earliest attempts to protect against infectious diseases
1:45 - 2:30 Bergman, Philip
Dr. Philip Bergman, BrightHeart Veterinary Centers, Armonk, NY
Of Mice & Men (& Dogs!): Therapeutic Vaccines for Cancer??
2:30 - 3:15 Kawaoka, Yoshi
Dr. Yoshi Kawaoka, Department of Pathobiological Sciences, Influenza Research Institute, University of Wisconsin-Madison
Why influenza kills and how to prevent it from killing again
3:15 - 3:30 Break
3:30 – 4:15 Cook, Mark
Dr. Mark Cook, Department of Animal Sciences, University of Wisconsin-Madison
Vaccination Taxation
4:15 – 5:00 Suresh, M.
Dr. M. Suresh, Department of Pathobilogical Sciences, University of Wisconsin-Madison
Cell Cycle Regulator p27Kip1 Constrains the Quantity and Quality of CD8 T Cell Memory by Regulating the Number of Memory Precursor Effector Cells
5:00 – 5:30 Walker, John
Dr. John Walker, Pfizer Animal Health, Parkville Australia
Peptide conjugate vaccines for immuno-contraception - commercialization by species
5:30 - 6:00 Q&A
6:30 – 9:30 Opening Reception

 

 

Monday, July 20
Bovine AM Session A : 8:15 – 12:00
Co-Chairs: Dr. Pat Shewen and Dr. Jim Roth

8:15 – 8:30 Intro by Co-Chairs
8:30-9:00 Collins, Mike
Dr. Mike Collins, University of Wisconsin-Madison
Johne’s disease diagnostics: The right test at the right time for the right price
9:00 – 9:30 Talaat, Adel
Dr. Adel Talaat, School of Veterinary Medicine, University of Wisconsin- Madison
On the Road to Discovery of Novel Vaccines Against Johne’s Disease in Cattle
9:30 – 10:00 Baldwin, Cynthia
Dr. Cynthia Baldwin, Univ. of Mass, Dept. of Veterinary and Animal Science, Amherst MA
Involvement of bovine gamma delta T cells in the immune response stimulated by a protective vaccine against Leptospira serovar Hardjo
10:00 – 10:30 Break
10:30 – 11:00

Kehrli, Marcus
Dr. Marcus Kehrli, Agricultural Research Service, USDA, NADC,
Ames, IA
“Innovative disease prevention research and a few reasons for commercial failure.”

11:00 – 11:30 Potter, Andrew
Dr. Andrew Potter, Director and CEO, VIDO, Saskatoon, SK CANADA
“Vaccination as a tool to reduce shedding of shigatoxin-producing Escherichia coli by cattle”
11:30 – 12:00 Q&A or Poster Oral Presentations
12:00 – 1:30 Lunch


Bovine PM Session: 1:30 – 5:30
Co-Chairs: Dr. Gerhardt Schurig and Dr. Marcus Kehrli
1:30 – 1:45 Intro by Co-Chairs
1:45 – 2:15 Corbeil, Lynette
Dr. Lynette Corbeil, University of California-San Diego
Histophilus somni IbpA: diagnostic, protective and toxic domains
2:15 – 2:45 Shewen, Patricia
Dr. Patricia Shewen, Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario CANADA
Vaccination of Neonatal Calves: Obstacles and Opportunities
2:45 – 3:15

Czuprynski, Chuck
Dr. Chuck Czuprynski, Department of Pathobiological Sciences, University of Wisconsin-Madison
Bovine cell interactions with Mannheimia haemolytica and Histophilus somni

3:15 – 3:30 Break
3:30 – 4:00 Roth, James
Dr. James A. Roth, Director, Center for Food Security and Public Health
Executive Director, Institute for International Cooperation in Animal
Biologics, College of Veterinary Medicine, Iowa State University, Ames, Iowa 50011
Induction of T Cell-Mediated Immunity by Bovine Vaccines
4:00 – 4:30 Dubovi, Ed
Dr. Edward Dubovi, NY State Diagnostic Laboratory, Cornell University
Diagnostic Testing as a Key Component of a BVDV Control Program
4:30 – 5:30 Q&A or Poster Oral Presentations


Canine and Feline AM Session: 8:15 – 12:00
Co-Chairs: Dr. Max Appel and Dr. Fred Scott
8:15 – 8:30 Intro by Co-chairs
8:30 – 9:00 Lappin, Mike
Dr. Mike Lappin, Department of Clinical Sciences, Colorado State University, Ft. Collins, CO
Antibodies against feline tissues induced by vaccination
9:00 – 9:30 Lutz, Hans
Dr. Hans Lutz, Head, Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland
Diagnosis of Feline Leukemia Virus infection – the basis for eradication
9:30 – 10:00 LaFleur, Rhonda
Dr. Rhonda LaFleur, Intervet/Schering-Plough Animal Hlth, Elkhorn NE
A Novel Borrelia burgdorferi Bacterin that induces both OSPA and OSPC Borreliacidal Antibodies Protects Dogs against Lyme Disease
10:00 – 10:30 Break
10:30 – 11:00 Pardo, Camila
Dr. M. Camila Pardo, Merial, Athens GA
Prevention of Canine leptospirosis and leptospiruria caused by L. grippotyphosa, 15 months after last vaccination
11:00 – 11:30 Martella, Vito
Dr. Vito Martella, School of Veterinary Medicine, Bari, Italy
Discovery of new canine enteric viruses
11:30 – 12:00 Q&A or Poster Oral Presentations
12:00 – 1:30 Lunch


Canine & Feline PM Session: 1:30 - 5:30
Co-Chairs: Dr. Gilles Chappius, Dr. Skip Carmichael
1:15 – 1:45 Carmichael, Leland (Skip)
Dr. Leland (Skip) Carmichael, Baker Institute, Cornell University
Canine parvovirus type-2: Then and 31 years later.
1:45 – 2:15 Wasmoen, Terri
Dr. Terri Wasmoen, Sr. Director, Biological Research, Intervet/Schering Plough Inc., 21401 West Center Road, Elkhorn NE 68022
Canine Influenza Virus: Experimental disease and prevention with vaccination
2:15 – 2:45 Kapil, Sanjay
Dr. Sanjay Kapil, Oklahoma State Univ., Diagnostic Lab, Stillwater OK
Canine Parvovirus: An Emerging, Reemerging Significant Pathogen of Dogs
2:45 – 3:15 Dodds, W.J.
Dr. Jean Dodds, Hemopet, Santa Monica, CA.
Compliance or resistance to current vaccine guidelines?
3:15 – 3:30 Break
3:30 – 4:00 Ford, Rich
Dr. Rich Ford, North Carolina State University, College of Vet Medicine
"Post-vaccinal Ischemic Vasculitis in Dogs: Satellite Skin Lesions"
4:00 – 4:30 Moore, George
Dr. George Moore, Purdue University, West Layfayette IN
Antigenic Causes of Vaccine-Associated Allergic Reactions in Dogs
4:30 – 5:00 Osorio, J.E.
Dr. Jorge Osorio, Department of Pathobiological Sciences, University of Wisconsin-Madison
Development of oral raccoon pox based vaccines that protect black- tailed prairie dogs against plague
5:00 – 5:30 Decaro, Nicola
Dr. Nicola Decaro, School of Veterinary Medicine, Bari, Italy
An Update on Canine Coronaviruses
5:30 – 6:00 Q&A

 

 

Tuesday, July 21
Canine/Feline AM Session: 8:15 – 12:00
Co-Chairs: Dr. Ilona Rodan, Dr. Mike Paul

8:15 - 8:30 Intro by Co-Chairs
8:30 – 9:00 Leutenegger, Christian
Dr. Christian Leutenegger, Idexx Laboratories, Sacramento, CA
Molecular Diagnostics and Vaccination: Dealing with Interference and Rates of False Positive Results
9:00 – 9:30 Evermann, Jim
Dr. James Evermann, Washington State University, Diagnostic Lab
Evolution of a Diagnosis: The Technology is Changing, but the Basic Principles Remain the Same
9:30 – 10:00 Pedersen, Niels
Dr. Niels Pedersen, UC-Davis, Davis CA
Feline infectious Peritonitis– Dilemmas of diagnosis, treatment and vaccination
10:00 – 10:30 Break
10:30 – 11:00 Leard, Tim
Dr. Timothy Leard, Merial, Athens, GA
Animal Health Vaccine, The Path to Licensure – Canine Melanoma DNA Vaccine
11:00 – 11:30 Schultz, Ronald
Dr. Ronald Schultz, Department of Pathobiological Sciences, University of Wisconsin-Madison
Canine and Feline Vaccine Questions: Do We Have the Answers?
11:30 – 12:00 Q&A – Roundtable
12:00 – 1:30 Lunch


Swine PM Session: 1:30 – 5:45
Co-Chairs: Dr. Joan Lunney and Dr. Chris Olsen
1:30 – 1:45 Intro by Chairs
1:45 – 2:30 Butler, J.E.
Dr. J.E. Butler, Dept. of Microbiology, University of Iowa
The effect of PRRSV, SIV and PCV-2 on the humoral immune system of germfree isolator piglets
2:30 – 3:15 Murtaugh, Michael
Dr. Michael Murtaugh, Dept. of Veterinary and Biomedical Sciences, University of Minnesota
Imunological Constraints on Vaccine Development for PRRS
3:15 – 3:30 Break
3:30 – 4:15 Saif, Linda
Dr. Linda Saif, Food Animal Health Research Program, OARDC, Dept. Veterinary Preventive Med, The Ohio State University, Wooster, OH USA
Gut reactions to rotavirus vaccines in a gnotobiotic piglet disease model: a priming lesion for neonatal mucosal immunity
4:15 – 4:45 Yoo, Han Sang
Dr. Han Sang Yoo, Professor, Seoul National University
A novel swine atrophic rhinitis vaccine candidate that induces mucosal immune responses by delivery systems based on chitosan microspheres
4:45 – 5:15 Thacker, Eileen
Dr. Eileen Thacker, USDA-Agricultural Research Service, Beltsville MD
The Autogenous Option
5:15 – 5:45

Vincent, Amy
Dr. Amy Vincent, National Animal Disease Center, USDA, ARS, Ames IA
Aggravated pneumonia induced by mismatched inactivated influenza virus vaccines."

 

Equine AM Session: 8:00 – 12:00
Co-Chairs: Dr. Dave Horohov, Dr. Paul Lunn
8:00 – 8:30 Intro by David Horohov, University of Kentucky
8:30 – 9:15 Hines, Steve
Dr. Steve Hines, Washington State University, Pulllman, WA
Rhodococcus equi - immunity and strategies for prevention
9:15 – 9:45 Adams, Amanda
Dr. Amanda Adams, Maxwell H. Gluck Equine Research Center, University of KY
Comparison of humoral and cell-mediated immune responses of young and old horses following influenza recombinant canarypox virus vaccination and challenge
9:45 – 10:15 Chang, Yu-Wei
Dr. Yu-Wei Chang, Fort Dodge Animal Health
Development and Registration of Fort Dodge Animal Health’s West Nile Virus Vaccines
10:15 – 10:30

Break

10:30 – 11:00 Vaala, Wendy
Dr. Wendy Vaala, Intervet/Schering Plough
PreveNile and WNV prevention
11:00 – 11:30 Lunn, Paul
Dr. Paul Lunn, Colorado State University
New diseases, new vaccines, old challenges: the equine balance sheet
11:30 – 12:00 Q&A and/or poster presentations
12:00 – 1:30 Lunch

 

Equine PM Session: 1:30 – 5:30
Co-Chairs: Dr. Dave Horohov and Dr. Paul Lunn
1:30 – 1:45 Intro by Co-Chairs
1:45 – 2:15 Minke, Jules
Dr. Jules Minke, Merial, Lyon France
Field experience on ProteqFluฎ during the Australian outbreak
2:15 – 2:45 Osterrieder, Klaus
Dr. Klaus Osterrieder, Institut fur Virologie, Freie Universitat Berlin
Equine Herpesvirus Type 1 – Novel Vectored Vaccines
2:45 – 3:15 Landolt, Gabi
Dr. Gabi Landolt, Colorado State Univ., Ft. Collins, CO
Past the Point of No Return? Of Horses, Dogs, and Influenza
3:15 – 3:30 Break
3:30 – 4:00 Timoney, John
Dr. John Timoney, Professor, Dept. of Veterinary Science, Maxwell H. Gluck Equine Research Ctr., University of KY, Lexington, KY
Genomes of Streptococcus equi and zooepidemicus: Rosetta stones for strangles vaccine improvement?
4:00 – 4:30 Stenbohm, Bob
Dr. Bob Stenbohm, Boehringer Ingelheim, St. Joseph, Missouri
Evaluation of the humoral immune response and fecal shedding in weaning foals following oral and intra-rectal administration of an avirulent live vaccine of Lawsonia intracellularis
4:30 – 5:00 Gershwin, Laurel
Dr. Laurel Gershwin, Professor of Immunology, University of California- Davis
Equine Vaccine Hypersensitivity
5:00 – 5:30 Q&A


Wednesday, July 22
New technologies to design vaccines for the control and eradication of transboundary diseases (FAD) Session AM: 8:30 – 12:00
Co-Chairs: Dr. Cyril Gay, Dr. Paul-Pierre Pastoret

8:30 – 8:45 Intro by Co-Chairs
8:45 – 9:30 Pastoret, Paul-Pierre
Dr. Paul-Pierre Pastoret, OIE, World Organisation for Animal Health, Paris, France
Vaccines in relation to trade and new and emerging technologies
9:30 – 10:15 Rodriguez, Luis
Dr. Luis Rodriguez, USDA/ARS Plum Island Animal Disease Center
The importance of basic research for the rational design of vaccines
10:15 – 10:30 Break
10:30 – 11:00 MacLachlan, Jim
Dr. James MacLachlan, Department of Pathology, Microbiology and Immunology, UC-Davis
Recombinant Canarypox Virus Vaccines to Prevent Emerging Orbivirus Diseases of Livestock
11:00 – 11:30 Vincent, Amy
Dr. Amy Vincent, NADC, ARS, Ames IA
New technologies to control Swine Influenza Virus
11:30 – 12:00 Posters
12:00 – 1:30 Lunch

 

New technologies to design vaccines for the control and eradication of transboundary diseases (FAD) Session PM: 1:00 – 4:30
Co-Chairs: Dr. Cyril Gay, Dr. Paul-Pierre Pastoret
1:00 – 1:15 Intro by Co-Chairs
1:15 – 1:45 Dr. Cyril Gay
United States Dept. of Agriculture, Agriculture Research Service, Animal Production and Protection, Beltsville, Maryland
New technologies to control Foot-and-Mouth Disease
1:45 – 2:15 Drew, Trevor
Dr. Trevor Drew, Veterinary Laboratories Agency, Weybridge, England
New technologies to control Classical Swine Fever (CSF)
2:15 – 2:45 Dungu, Baty
Dr. Baty Dungu, GALVmed, Edinburgh, Scotland
Prospects for improved Rift Valley Fever (RVF) vaccines
2:45 – 3:00 Break
3:00 – 3:30 Greenlee, Justin
Dr. Justin Greenlee, Virus and Prion Diseases of Livestock Research Unit, National Animal Disease Center, Ames IA
New Potentials in TSE diagnostics
3:30 – 4:00 Posters
4:00 – 4:30 Q&A
EVENING Concert on the Square

 

Avian/Aquatic AM Session: 8:30 – 12:00
Co-Chairs: Dr. Phil Klesius and Dr. Stacey Schultz-Cherry
8:30 – 8:45 Intro by Co-Chairs
8:45 – 9:30 Afonso, Claudio
Dr. Claudo Afonso, USDA-ARS, Southeast Poultry Research Lab, Athens, GA
New strategies to control virulent Newcastle disease
9:30 – 10:00 Schultz-Cherry, Stacey
Dr. Stacey Schultz-Cherry, Dept. Medical Microbiology, University of Wisconsin-Madison
Astroviruses: Lessons learned from turkeys
10:00 – 10:30 Break
10:30 – 11:00 Saif, Mo
Dr. Mo Saif, Ohio State University, Department of Animal Sciences, Columbus, OH
Influenza Vaccines for Turkeys
11:00 – 11:45 Klesius, Phillip
Dr. Phillip Klesius, United States Dept. of Agriculture, Agricultural Research Service, Aquatic Animal Health Research Laboratory, Auburn AL and Chestertown MD USA
Fish Vaccines: Current State and Future Advances
11:45 – 12:00 Poster Session
12:00 – 1:30 Lunch

 

Avian/Aquatic PM Session: 1:30 – 4:30
Co-Chairs: Dr. Phil Klesius and Dr. Kathy Kurth
1:30 – 1:45 Intro by Co-Chairs
1:45 – 2:15 Adams, Alexandra
Dr. Alexandra Adams, Institute of Aquaculture, Stirling, Scotland UK
Novel approaches to fish vaccine development
2:15 – 2:45 Shoemaker, Craig
Dr. Craig A. Shoemaker, USDA, Aquatic Animal Health Reseach Lab, Auburn AL
Development and use of a modified live Flavobacterium columnare vaccine in fish
2:45 – 3:15 Kurth, Kathy
Dr. Kathy Kurth, Wisconsin Veterinary Diagnostic Lab, Madison WI
Emerging Aquatic Viruses in Wisconsin
3:15 – 3:30 Break
3:30 – 4:00 N. Mirhossenini
Dr. N. Mirhosseini, Texas A&M University, College Station, TX
Serologic and molecular diagnosis of avian borna virus infection.
4:00 - 4:30 Cook, Stephanie
Dr. Stephanie Cook, Intervet Schering-Plough, Elkhorn, NE
A Marek's Disease Virus Recombinant Vaccine to Control ILT and Marek's Disease Siumltaneously.
4:30 –5:00 Q&A and/or poster presentations
EVENING Concert on the Square

 

 

Thursday, July 23
General Session: 8:30 – 11:45
Co-Chairs: Dr. Chuck Czuprynski and Dr. Gary Splitter

8:30 – 8:45 Intro by Co-Chairs
8:45 – 9:30 Audonnet, Jean-Christophe
Dr. Jean-Christophe Audonnet, Merial, Lyon France
20 years of experience with ALVAC as a vector for veterinary vaccines.
9:30 – 10:15 Rouse, Barry
Dr. Barry Rouse, University of Tennessee-Knoxville
Immunopathology versus immunity in viral infections
10:15 – 11:00 Bror Morein
Dr. Bror Morein, Swedish University of Agricultural Sciences, Department of Veterinary Microbiology, Uppsala, Sweden
ISCOM Technology: It’s Importance in Designing Veterinary Vaccines
11:00 – 11:45 Meeusen, Els
Dr. Els Meeusen, Animal Biotech Research Laboratory, Dept. of Physiology, School of Biomedical Sciences, Monash Univ, Victoria, Australia
Adjuvants in the real world – how do they work?
11:45 – 1:00 Lunch

 

General Session PM: 1:00 – 4:30
Co-Chairs: Dr. Gary Splitter and Dr. Els Meeusen
1:00 – 1:15 Intro by Co-Chairs
1:15 – 2:00 Lunney, Joan
Dr. Joan Lunney, Animal Parasitic Diseases Lab, ANRI, ARS, USDA
Genetic approaches to reveal immune response pathways and viral antigen targets for novel vaccine design
2:00 – 2:45

Splitter, Gary
Dr. Gary Splitter, Department of Pathobiological Sciences, University of Wisconsin-Madison
Unraveling the secrets of Brucell abortus

2:45 - 3:30 Wiegers, Ann
Dr. Ann Wiegers, CVB, APHIS, USDA, Ames, IA
General Licensing Requirements for Veterinary Biologics in the United States
3:30 – 4:00

Trujillo, Jessie
Dr. Jessie Trujillo, Utah Veterinary Diagnostic Laboratory, Animal, Dairy and Veterinary Services, Utah State University, Logan UT
Overcoming Deceptive Imprinting: Immune Refocusing Technology as a Proof-of-Concept using the Caprine Arthritis Encephalitis Virus (CAEV) Vaccine Model           

4:00 – 4:30 Concluding Remarks – Dr. Ronald D. Schultz